3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-

Request For Quotation
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Suppliers list
Company Name: Shanghai Changyan Chem & Tech Co., Ltd.  
Tel: 021-20242659 18930833303
Email: sales@changyanchem.cn
Company Name: Scinova Biotech(Guangzhou) Co., Ltd.  
Tel: 13268215580
Email: scinova_sales@163.com
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD  
Tel: 18126517264
Email: 2850476883@qq.com
Company Name: Hubei Moco Chemical Co., Ltd.  
Tel: 18627753421; 18627756402
Email: 3001051413@qq.com
Company Name: Guangzhou Viocon Pharmaceutical Technology Co., Ltd  
Tel: +86-13424074264; 13726739909
Email: chenhuini@cti-cert.com

3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- manufacturers
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Basic information
Product Name:3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
Synonyms:3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
CAS:2097982-05-1
MF:C13 H19 N5
MW:245.32
EINECS:
Product Categories:
Mol File:2097982-05-1.mol
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Structure
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Chemical Properties
Safety Information
MSDS Information
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Usage And Synthesis
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Preparation Products And Raw materials
Tag:3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-(2097982-05-1) Related Product Information
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) (3S,4S)-Tofacitinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile Tofacitinib Impurity 6 2,4-Dichloro-7H-pyrrolo2,3-dpyrimidine